-
Sector Analysis
NewUrea Capacity and Capital Expenditure Outlook by Region, Countries, Companies, Projects and Forecast to 2030
Urea Industry Capacity & Capital Expenditure (Capex) Overview The urea capacity was 241.92 million tonnes per annum (mtpa) in 2023. The use of urea as fertilizer in the agriculture industry and for industrial applications such as for production of plastics is driving global urea demand. Furthermore, Asia, FSU, and the Middle East will primarily drive the global Urea capacity growth during the outlook period. Urea Industry Capacity and Capex Outlook, 2024-2030 (mtpa) Buy the Full Report for More Insights into...
-
Product Insights
NewPT Halmahera Persada Lygend Project
PT Halmahera Persada Lygend Project is a nickel mining project located in Kawasi, Obi, South Halmahera Regency, North Maluku, Indonesia. Empower your strategies with our PT Halmahera Persada Lygend Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data...
-
Product Insights
NewPT Huayue Nickel Cobalt Project
PT Huayue Nickel Cobalt Project is located in Labota, Central Sulawesi, Indonesia. Empower your strategies with our PT Huayue Nickel Cobalt Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Gain vital...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Deflexifol in Metastatic Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Deflexifol in Metastatic Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Deflexifol in Metastatic Colorectal Cancer Drug Details: Deflexifol is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AXA-042 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AXA-042 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AXA-042 in Solid Tumor Drug Details: AXA-042 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Imifoplatin in Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Imifoplatin in Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Imifoplatin in Ovarian Cancer Drug Details: PT-112 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Imifoplatin in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Imifoplatin in Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Imifoplatin in Pancreatic Cancer Drug Details: PT-112 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Imifoplatin in Thymoma (Thymic Epithelial Tumor)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Imifoplatin in Thymoma (Thymic Epithelial Tumor) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Imifoplatin in Thymoma (Thymic Epithelial Tumor) Drug Details: PT-112...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Belzutifan in Pheochromocytoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Belzutifan in Pheochromocytoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Belzutifan in Pheochromocytoma Drug Details: Belzutifan (Welireg) is an anti-cancer agent. It...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DN-1508052 in Malignant Pleural Mesothelioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DN-1508052 in Malignant Pleural Mesothelioma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DN-1508052 in Malignant Pleural Mesothelioma Drug Details: DN-1508052 is under...